Literature DB >> 16944095

End-stage renal disease risk equations for Hong Kong Chinese patients with type 2 diabetes: Hong Kong Diabetes Registry.

X L Yang1, W Y So, A P S Kong, P Clarke, C S Ho, C W K Lam, M H L Ng, R R Lyu, D D Yin, C C Chow, C S Cockram, P C Y Tong, J C N Chan.   

Abstract

AIMS/HYPOTHESIS: The objective of the study was to investigate risk factors and develop risk equations for end-stage renal disease (ESRD) in Chinese patients with type 2 diabetes. SUBJECTS AND METHODS: A prospective cohort of 4,438 patients with type 2 diabetes mellitus and without ESRD (median observation period 2.9 years, interquartile range 1.6-4.1 years) was included in the analysis. The end-point (ESRD) was defined by: (1) death due to diabetes with renal manifestations or renal failure; (2) hospitalisation due to renal failure; (3) estimated GFR (eGFR) <15 ml min(-1) 1.73 m(-2). Cox proportional hazards regression was used to develop risk equations. The data were randomly and evenly divided into the training data for development of the risk equations and the test data for validation. The validation was performed using the area under the receiver operating characteristic curve (aROC), which takes into account follow-up time and censoring.
RESULTS: During the observation period, 159 patients or 12.45 per 1,000 person-years (95% CI 10.52-14.37 per 1,000 person-years) developed ESRD. Known duration of diabetes, systolic blood pressure, log(10) total cholesterol:HDL cholesterol ratio and retinopathy were significant predictors of ESRD. After further adjusting for eGFR, log(10) spot albumin:creatinine ratio (ACR) and haematocrit, only eGFR, haematocrit and log(10) ACR remained as independent predictors of ESRD. The risk equation derived from these three independent predictors had good discrimination, with an aROC of 0.97. CONCLUSIONS/
INTERPRETATION: Estimated GFR, haematocrit and ACR were independent predictors of ESRD and the derived risk equation performed well in Chinese patients with type 2 diabetes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16944095     DOI: 10.1007/s00125-006-0376-3

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  50 in total

1.  An alarmingly high prevalence of diabetic nephropathy in Asian type 2 diabetic patients: the MicroAlbuminuria Prevalence (MAP) Study.

Authors:  A Y T Wu; N C T Kong; F A de Leon; C Y Pan; T Y Tai; V T F Yeung; S J Yoo; A Rouillon; M R Weir
Journal:  Diabetologia       Date:  2004-12-23       Impact factor: 10.122

2.  Effects of structured care by a pharmacist-diabetes specialist team in patients with type 2 diabetic nephropathy.

Authors:  Wilson Y S Leung; Wing-Yee So; Peter C Y Tong; Norman N Chan; Juliana C N Chan
Journal:  Am J Med       Date:  2005-12       Impact factor: 4.965

3.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

Authors:  W T Friedewald; R I Levy; D S Fredrickson
Journal:  Clin Chem       Date:  1972-06       Impact factor: 8.327

Review 4.  Genetics of diabetic nephropathy.

Authors:  H H Parving; L Tarnow; P Rossing
Journal:  J Am Soc Nephrol       Date:  1996-12       Impact factor: 10.121

5.  Prevalence of diabetes and its risk factors in China, 1994. National Diabetes Prevention and Control Cooperative Group.

Authors:  X R Pan; W Y Yang; G W Li; J Liu
Journal:  Diabetes Care       Date:  1997-11       Impact factor: 19.112

6.  Assessment of glomerular filtration rate in addition to albuminuria is important in managing type II diabetes.

Authors:  A P S Kong; W Y So; C C Szeto; N N Chan; A Luk; R C W Ma; R Ozaki; V W S Ng; C S Ho; C W K Lam; C C Chow; C S Cockram; J C N Chan; P C Y Tong
Journal:  Kidney Int       Date:  2006-01       Impact factor: 10.612

7.  The conundrum of increased burden of end-stage renal disease in Asians.

Authors:  Yoshio N Hall; Chi-yuan Hsu; Carlos Iribarren; Jeanne Darbinian; Charles E McCulloch; Alan S Go
Journal:  Kidney Int       Date:  2005-11       Impact factor: 10.612

Review 8.  Albuminuria reflects widespread vascular damage. The Steno hypothesis.

Authors:  T Deckert; B Feldt-Rasmussen; K Borch-Johnsen; T Jensen; A Kofoed-Enevoldsen
Journal:  Diabetologia       Date:  1989-04       Impact factor: 10.122

9.  Cigarette smoking exacerbates and its cessation ameliorates renal injury in type 2 diabetes.

Authors:  Temduang Chuahirun; Jan Simoni; Cathy Hudson; Timothy Seipel; Apurv Khanna; Ronald B Harrist; Donald E Wesson
Journal:  Am J Med Sci       Date:  2004-02       Impact factor: 2.378

10.  White blood cell count is associated with macro- and microvascular complications in chinese patients with type 2 diabetes.

Authors:  Peter C Tong; Ka-Fai Lee; Wing-Yee So; Margaret H Ng; Wing-Bun Chan; Matthew K Lo; Norman N Chan; Juliana C Chan
Journal:  Diabetes Care       Date:  2004-01       Impact factor: 19.112

View more
  26 in total

1.  Diabetes, insulin and cancer risk.

Authors:  Xi-Lin Yang; Juliana Cn Chan
Journal:  World J Diabetes       Date:  2012-04-15

2.  Modified end-stage renal disease risk score for Chinese type 2 diabetic patients--the Hong Kong Diabetes Registry.

Authors:  X L Yang; W Y So; A P S Kong; C S Ho; C W K Lam; M H L Ng; R R Lyu; D D Yin; C C Chow; C S Cockram; P C Y Tong; J C N Chan
Journal:  Diabetologia       Date:  2007-04-13       Impact factor: 10.122

3.  From design to implementation--the Joint Asia Diabetes Evaluation (JADE) program: a descriptive report of an electronic web-based diabetes management program.

Authors:  Gary T Ko; Wing-Yee So; Peter C Tong; Francois Le Coguiec; Debborah Kerr; Greg Lyubomirsky; Beaver Tamesis; Troels Wolthers; Jennifer Nan; Juliana Chan
Journal:  BMC Med Inform Decis Mak       Date:  2010-05-13       Impact factor: 2.796

4.  Independent associations between low-density lipoprotein cholesterol and cancer among patients with type 2 diabetes mellitus.

Authors:  Xilin Yang; WingYee So; Gary T C Ko; Ronald C W Ma; Alice P S Kong; Chun-Chung Chow; Peter C Y Tong; Juliana C N Chan
Journal:  CMAJ       Date:  2008-08-26       Impact factor: 8.262

5.  Clinical Predictors and Long-term Impact of Acute Kidney Injury on Progression of Diabetic Kidney Disease in Chinese Patients With Type 2 Diabetes.

Authors:  Guozhi Jiang; Andrea O Luk; Claudia H T Tam; Risa Ozaki; Cadmon K P Lim; Elaine Y K Chow; Eric S Lau; Alice P S Kong; Baoqi Fan; Ka Fai Lee; Shing Chung Siu; Grace Hiu; Chiu Chi Tsang; Kam Piu Lau; Jenny Y Leung; Man-wo Tsang; Grace Kam; Ip Tim Lau; June K Li; Vincent T Yeung; Emmy Lau; Stanley Lo; Samuel Fung; Yuk Lun Cheng; Chun Chung Chow; Nelson L S Tang; Yu Huang; Hui-yao Lan; Richard A Oram; Cheuk Chun Szeto; Wing Yee So; Juliana C N Chan; Ronald C W Ma
Journal:  Diabetes       Date:  2022-03-01       Impact factor: 9.461

6.  Effects of proactive population-based nephrologist oversight on progression of chronic kidney disease: a retrospective control analysis.

Authors:  Brian Lee; Marianne Turley; Di Meng; Yvonne Zhou; Terhilda Garrido; Alan Lau; Linda Radler
Journal:  BMC Health Serv Res       Date:  2012-08-15       Impact factor: 2.655

7.  The Complexity of Vascular and Non-Vascular Complications of Diabetes: The Hong Kong Diabetes Registry.

Authors:  Juliana C N Chan; Wingyee So; Ronald C W Ma; Peter C Y Tong; Rebecca Wong; Xilin Yang
Journal:  Curr Cardiovasc Risk Rep       Date:  2011-04-12

8.  Evaluation of the quality of care of a multi-disciplinary risk factor assessment and management programme (RAMP) for diabetic patients.

Authors:  Colman S C Fung; Weng Yee Chin; Daisy S K Dai; Ruby L P Kwok; Eva L H Tsui; Yuk Fai Wan; Wendy Wong; Carlos K H Wong; Daniel Y T Fong; Cindy L K Lam
Journal:  BMC Fam Pract       Date:  2012-12-05       Impact factor: 2.497

9.  Impacts of chronic kidney disease and albuminuria on associations between coronary heart disease and its traditional risk factors in type 2 diabetic patients - the Hong Kong diabetes registry.

Authors:  Xilin Yang; Ronald C Ma; Wing-Yee So; Gary T Ko; Alice P Kong; Christopher W Lam; Chun-Shun Ho; Clive S Cockram; Vivian C Wong; Peter C Tong; Juliana C Chan
Journal:  Cardiovasc Diabetol       Date:  2007-12-02       Impact factor: 9.951

10.  Development and validation of a risk score for hospitalization for heart failure in patients with Type 2 diabetes mellitus.

Authors:  Xilin Yang; Ronald C Ma; Wing-Yee So; Alice P Kong; Gary T Ko; Chun-Shun Ho; Christopher W Lam; Clive S Cockram; Peter C Tong; Juliana C Chan
Journal:  Cardiovasc Diabetol       Date:  2008-04-22       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.